{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:05Z","timestamp":1791644405681,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.mtbio.2024.101206","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T19:46:09Z","timestamp":1723837569000},"page":"101206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"Abdulmottaleb E.","family":"Zetrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar Z.","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HoYin","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alradwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Rauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-8115","authenticated-orcid":false,"given":"Xiao Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2024.101206_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.mtbio.2024.101206_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1405491","article-title":"Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies","volume":"14","author":"Xiong","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2024.101206_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-020-01501-x","article-title":"Recent advances in radiotherapy of breast cancer","volume":"15","author":"Haussmann","year":"2020","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.mtbio.2024.101206_bib4","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular pathways: overcoming radiation resistance by targeting DNA damage response pathways","volume":"21","author":"Morgan","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2024.101206_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2024.101206_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.mtbio.2024.101206_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00412-017-0658-1","article-title":"Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes","volume":"127","author":"Ranjha","year":"2018","journal-title":"Chromosoma"},{"key":"10.1016\/j.mtbio.2024.101206_bib8","doi-asserted-by":"crossref","first-page":"S875","DOI":"10.21037\/tcr.2017.06.02","article-title":"Translational research in radiation-induced DNA damage signaling and repair","volume":"6","author":"Nickoloff","year":"2017","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.mtbio.2024.101206_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-biochem-062917-012415","article-title":"The MRE11\u2013RAD50\u2013NBS1 complex conducts the orchestration of damage signaling and outcomes to stress in DNA replication and repair","volume":"87","author":"Syed","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.mtbio.2024.101206_bib10","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1007\/s00018-016-2262-6","article-title":"Coupling end resection with the checkpoint response at DNA double-strand breaks","volume":"73","author":"Villa","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.mtbio.2024.101206_bib11","doi-asserted-by":"crossref","first-page":"11200","DOI":"10.1073\/pnas.0802885105","article-title":"MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks","volume":"105","author":"Wu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mtbio.2024.101206_bib12","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1101\/gad.914401","article-title":"Cell cycle checkpoint signaling through the ATM and ATR kinases","volume":"15","author":"Rt","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.mtbio.2024.101206_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1158\/1078-0432.CCR-17-1455","article-title":"RAD50 expression is associated with poor clinical outcomes after radiotherapy for resected non\u2013small cell lung CancerPrognostic role of RAD50 in resected NSCLC","volume":"24","author":"Wang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2024.101206_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1568009620666201009125507","article-title":"Overexpression of RAD50 is the marker of poor prognosis and drug resistance in breast cancer patients","volume":"21","author":"Karamat","year":"2021","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.mtbio.2024.101206_bib15","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/febs.15588","article-title":"Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem\u2010like cells contributes to chemoresistance","volume":"288","author":"Abad","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.mtbio.2024.101206_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ygyno.2016.01.004","article-title":"Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer","volume":"141","author":"Zhang","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.mtbio.2024.101206_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4161\/cbt.28551","article-title":"RAD50 targeting impairs DNA damage response and sensitizes human breast cancer cells to cisplatin therapy","volume":"15","author":"Flores-P\u00e9rez","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.mtbio.2024.101206_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2190-8","article-title":"Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy","volume":"16","author":"Chang","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mtbio.2024.101206_bib19","first-page":"1","article-title":"Frameworks for transformational breakthroughs in RNA-based medicines","author":"Androsavich","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2024.101206_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.canlet.2018.09.011","article-title":"RNA interference to enhance radiation therapy: targeting the DNA damage response","volume":"439","author":"Ratnayake","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mtbio.2024.101206_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ctrv.2016.08.004","article-title":"RNA-targeted therapeutics in cancer clinical trials: current status and future directions","volume":"50","author":"Barata","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.mtbio.2024.101206_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.mtbio.2024.101206_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202300005","article-title":"Non\u2010viral nucleic acid delivery system for RNA therapeutics","volume":"6","author":"Liu","year":"2023","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.mtbio.2024.101206_bib24","article-title":"Non-viral nucleic acid delivery approach: a boon for state-of-the-art gene delivery","volume":"80","author":"Sahu","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.mtbio.2024.101206_bib25","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/jcb.29580","article-title":"Prognostic implication and functional annotations of Rad50 expression in patients with prostate cancer","volume":"121","author":"Xu","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mtbio.2024.101206_bib26","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.biomac.8b00546","article-title":"Small delivery vehicles of siRNA for enhanced cancer targeting","volume":"19","author":"Kim","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.mtbio.2024.101206_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnano.2021.694838","article-title":"RNA interference and nanotechnology: a promising alliance for next generation cancer therapeutics","volume":"3","author":"Swaminathan","year":"2021","journal-title":"Frontiers in Nanotechnology."},{"key":"10.1016\/j.mtbio.2024.101206_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J.Controlled Release"},{"key":"10.1016\/j.mtbio.2024.101206_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2024.101206_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.644718","article-title":"Insight into the prospects for RNAi therapy of cancer","volume":"12","author":"Tian","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mtbio.2024.101206_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/17425247.2024.2318459","article-title":"An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism","volume":"21","author":"Ahmed","year":"2024","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.mtbio.2024.101206_bib32","first-page":"1","article-title":"The 60-year evolution of lipid nanoparticles for nucleic acid delivery","author":"Cullis","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mtbio.2024.101206_bib33","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mtbio.2024.101206_bib34","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1021\/acs.accounts.9b00368","article-title":"Lipid nanoparticle technology for clinical translation of siRNA therapeutics","volume":"52","author":"Kulkarni","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.mtbio.2024.101206_bib35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug.Chem."},{"key":"10.1016\/j.mtbio.2024.101206_bib36","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.3390\/ijms23168838","article-title":"Monitoring anti-PEG antibodies level upon repeated lipid nanoparticle-based COVID-19 vaccine administration","volume":"23","author":"Guerrini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2024.101206_bib37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/17425247.2021.1902984","article-title":"Exploring the transformability of polymer-lipid hybrid nanoparticles and nanomaterial-biology interplay to facilitate tumor penetration, cellular uptake and intracellular targeting of anticancer drugs","volume":"18","author":"Amini","year":"2021","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.mtbio.2024.101206_bib38","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s11095-021-03122-9","article-title":"Optimizing the design of blood\u2013brain barrier-penetrating polymer-lipid-hybrid nanoparticles for delivering anticancer drugs to glioblastoma","volume":"38","author":"Ahmed","year":"2021","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.mtbio.2024.101206_bib39","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1021\/nn501069c","article-title":"A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood\u2013brain barrier targeting brain metastases of breast cancer","volume":"8","author":"Li","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.mtbio.2024.101206_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900543","article-title":"Multitargeted nanoparticles deliver synergistic drugs across the blood\u2013brain barrier to brain metastases of triple negative breast cancer cells and tumor\u2010associated macrophages","volume":"8","author":"Zhang","year":"2019","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.mtbio.2024.101206_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2024.100954","article-title":"Biocompatible and bioactivable terpolymer-lipid-MnO2 Nanoparticle-based MRI contrast agent for improving tumor detection and delineation","volume":"25","author":"Yen","year":"2024","journal-title":"Materials Today Bio"},{"key":"10.1016\/j.mtbio.2024.101206_bib42","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/adfm.201404511","article-title":"Design of hybrid MnO2\u2010polymer\u2010lipid nanoparticles with tunable oxygen generation rates and tumor accumulation for cancer treatment","volume":"25","author":"Gordijo","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2024.101206_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201705668","article-title":"Two\u2010step targeted hybrid nanoconstructs increase brain penetration and efficacy of the therapeutic antibody trastuzumab against brain metastasis of HER2\u2010positive breast cancer","volume":"28","author":"He","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.mtbio.2024.101206_bib44","article-title":"Brain\u2010Penetrating and disease site\u2010targeting manganese dioxide\u2010polymer\u2010lipid hybrid nanoparticles remodel microenvironment of Alzheimer's disease by regulating multiple pathological pathways","author":"Park","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mtbio.2024.101206_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.34133\/research.0247","article-title":"Remodeling tumor immune microenvironment by using polymer-lipid-manganese dioxide nanoparticles with radiation therapy to boost immune response of castration-resistant prostate cancer","volume":"6","author":"Zetrini","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.mtbio.2024.101206_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.colsurfb.2012.07.015","article-title":"Design of pH-responsive nanoparticles of terpolymer of poly (methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin","volume":"101","author":"Shalviri","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.mtbio.2024.101206_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2022.02.026","article-title":"Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts","author":"Lip","year":"2022","journal-title":"Radiother. Oncol.170"},{"key":"10.1016\/j.mtbio.2024.101206_bib48","doi-asserted-by":"crossref","first-page":"41056","DOI":"10.1021\/acsami.8b14001","article-title":"In situ proapoptotic peptide-generating rapeseed protein-based nanocomplexes synergize chemotherapy for cathepsin-B overexpressing breast cancer","volume":"10","author":"Wang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2024.101206_bib49","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/onc.2010.467","article-title":"PKB\/Akt promotes DSB repair in cancer cells through upregulating Mre11 expression following ionizing radiation","volume":"30","author":"Deng","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.mtbio.2024.101206_bib50","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.3390\/cancers13143438","article-title":"Exploiting DNA damage repair in precision cancer therapy: BRCA1 as a prime therapeutic target","volume":"13","author":"Raimundo","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mtbio.2024.101206_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2024.101206_bib52","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1158\/1078-0432.CCR-17-0802","article-title":"Sequential tracking of PD-L1 expression and RAD50 induction in circulating tumor and stromal cells of lung cancer patients undergoing RadiotherapyTracking PD-L1 and RAD50 in tumor-derived blood cells in NSCLC","volume":"23","author":"Adams","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2024.101206_bib53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/ph13100294","article-title":"Overcoming barriers for siRNA therapeutics: from bench to bedside","volume":"13","author":"Sajid","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.mtbio.2024.101206_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114904","article-title":"Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems","author":"Shi","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.mtbio.2024.101206_bib55","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.biomaterials.2010.12.057","article-title":"Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity","volume":"32","author":"Pittella","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2024.101206_bib56","first-page":"265","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems-a review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharmaceut. Res."},{"key":"10.1016\/j.mtbio.2024.101206_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","article-title":"Nanodelivery of nucleic acids","volume":"2","author":"Mendes","year":"2022","journal-title":"Nature Reviews Methods Primers"},{"key":"10.1016\/j.mtbio.2024.101206_bib58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s11914-020-00587-2","article-title":"Delivery of RNAi-based therapeutics for bone regeneration","volume":"18","author":"Malcolm","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.mtbio.2024.101206_bib59","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ymthe.2021.01.030","article-title":"Allergic reactions and anaphylaxis to LNP-based COVID-19 vaccines","volume":"29","author":"Moghimi","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mtbio.2024.101206_bib60","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.biomaterials.2012.11.058","article-title":"In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier","volume":"34","author":"Naeye","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.mtbio.2024.101206_bib61","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.02.021","article-title":"Revisiting structure-property relationship of pH-responsive polymers for drug delivery applications","volume":"253","author":"Bazban-Shotorbani","year":"2017","journal-title":"J.Controlled Release"},{"key":"10.1016\/j.mtbio.2024.101206_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1100-5","article-title":"MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment","volume":"18","author":"Bian","year":"2019","journal-title":"Mol. Cancer"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424002679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424002679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T04:56:41Z","timestamp":1730782601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006424002679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":62,"alternative-id":["S2590006424002679"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101206","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting DNA damage repair mechanism by using RAD50-silencing siRNA nanoparticles to enhance radiotherapy in triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101206","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101206"}}